title,time_published,url,ticker,relevance_score,ticker_sentiment_label,ticker_sentiment_score
Stocks That Hit 52-Week Lows On Friday,20220506T160650,https://www.benzinga.com/markets/options/22/05/27050916/52-weeks-high-and-low-article,ADVM,0.005467,Neutral,0.003623
Stocks That Hit 52-Week Lows On Thursday,20220428T193101,https://www.benzinga.com/markets/options/22/04/26872967/52-weeks-high-and-low-article,ADVM,0.00644,Neutral,0.001612
Stocks That Hit 52-Week Lows On Tuesday,20220315T163235,https://www.benzinga.com/news/22/03/26148458/stocks-that-hit-52-week-lows-on-tuesday,ADVM,0.00539,Neutral,0.016663
Here's Why You Should Invest in Adverum  ( ADVM )  Stock Now,20240104T132700,https://www.zacks.com/stock/news/2205527/heres-why-you-should-invest-in-adverum-advm-stock-now,ADVM,0.341857,Neutral,0.146479
Why Bloom Energy Group Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket - Bloom Energy  ( NYSE:BE ) ,20240717T100331,https://www.benzinga.com/news/24/07/39810902/why-bloom-energy-group-shares-are-trading-higher-by-12-here-are-20-stocks-moving-premarket,ADVM,0.211806,Somewhat-Bullish,0.250967
"Gene therapy market size to grow by USD 4.61 billion from 2022 to 2027, North America is estimated to contribute 39 ... - PR Newswire",20240318T093600,https://www.prnewswire.com/news-releases/gene-therapy-market-size-to-grow-by-usd-4-61-billion-from-2022-to-2027--north-america-is-estimated-to-contribute-39-to-the-growth-technavio-302090363.html,ADVM,0.033562,Neutral,0.019119
"Gene therapy market size to grow by USD 4,613.9 million from 2022 to 2027 | Growing research in gene therapy for ... - PR Newswire",20231201T073500,https://www.prnewswire.com/news-releases/gene-therapy-market-size-to-grow-by-usd-4-613-9-million-from-2022-to-2027--growing-research-in-gene-therapy-for-cvds-and-orphan-diseases-is-the-major-market-trend--technavio-302002646.html,ADVM,0.048523,Neutral,0.017903
"Gene Therapy Market size to grow by USD 4.61 billion from 2022 to 2027, North America to account for 39% of market ... - PR Newswire",20231103T223500,https://www.prnewswire.com/news-releases/gene-therapy-market-size-to-grow-by-usd-4-61-billion-from-2022-to-2027--north-america-to-account-for-39-of-market-growth--technavio-301976707.html,ADVM,0.074692,Neutral,0.0
"The Daily Biotech Pulse: Veru Seeks Emergency Use Nod For COVID-19 Therapy, Vincerx Cuts Workforce, Moderna Starts Dosing In Flu Vaccine Study",20220607T123117,https://www.benzinga.com/general/biotech/22/06/27583701/the-daily-biotech-pulse-veru-seeks-emergency-use-nod-for-covid-19-therapy-vincerx-cuts-workforce-,ADVM,0.10322,Neutral,-0.063705
12 Health Care Stocks Moving In Monday's Pre-Market Session,20220418T131808,https://www.benzinga.com/pre-market-outlook/22/04/26663649/12-health-care-stocks-moving-in-mondays-pre-market-session,ADVM,0.13775,Neutral,0.002162
"The Daily Biotech Pulse: Merck's Seagen Buyout Advances, Adverum Restructures, Pharmacists Get OK To Prescribe Pfizer COVID-19 Pill",20220707T140337,https://www.benzinga.com/general/biotech/22/07/27983728/the-daily-biotech-pulse-mercks-potential-seagen-buyout-expected-in-weeks-fda-holds-diamedicas-str,ADVM,0.19445,Neutral,0.002388
Stocks That Hit 52-Week Lows On Wednesday,20220420T161438,https://www.benzinga.com/news/22/04/26717868/stocks-that-hit-52-week-lows-on-wednesday,ADVM,0.015214,Neutral,0.00096
Stocks That Hit 52-Week Lows On Tuesday,20220419T153817,https://www.benzinga.com/news/22/04/26693085/stocks-that-hit-52-week-lows-on-tuesday,ADVM,0.009731,Neutral,-0.010138
